HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Lissencephaly — Clinical Guidelines

Overview

Lissencephaly is a severe congenital brain malformation characterized by the absence of normal cortical folding, resulting from defective neuronal migration during fetal development. It manifests as varying degrees of agyria (complete absence of gyri) or pachygyria (abundant, thickened gyri) and is associated with diverse genetic etiologies 1 3 10.

Diagnosis

Key Diagnostic Criteria: Abnormal cortical lamination, often detected by persistence of laminar pattern beyond 34 weeks gestation and abnormal cortical sulcation on fetal neurosonography 1.

Recommended Tests:

- Ultrasound (US): Initial imaging modality in newborns and infants 7. - MRI: Provides detailed visualization of cortical malformations and associated anomalies 7. - Genetic Testing: Essential for identifying specific genetic mutations (e.g., COQ2, ARX, LIS1) 1 2 3 10.

Grading: Imaging findings should be correlated with clinical presentation and genetic analysis for definitive diagnosis 7.

Management

Supportive Care: Focus on managing symptoms such as seizures, feeding difficulties, and respiratory support 1 7.

Seizure Control: Antiepileptic drugs tailored to individual patient needs (specific drug classes/doses not detailed in abstracts) 7.

Developmental Support: Early intervention programs for motor and cognitive development 7.

Nutritional Support: Address feeding difficulties with appropriate interventions (e.g., gastrostomy) 7.

Respiratory Care: Manage respiratory complications, possibly requiring mechanical ventilation 1 7.

Special Populations

Pregnancy: Prenatal diagnosis possible via ultrasound showing abnormal cortical development; genetic testing can identify causative mutations 1.

Pediatrics: Early neuroimaging crucial for diagnosis and management planning 7.

Comorbidities: Often associated with additional anomalies (e.g., corpus callosum agenesis, ambiguous genitalia) requiring multidisciplinary care 2 6 10.

Key Recommendations

Prenatal Ultrasound Screening: Perform detailed fetal neurosonography beyond 34 weeks gestation to detect lissencephaly 1. (Evidence: Moderate)

MRI for Detailed Assessment: Utilize MRI in neonates and infants for comprehensive evaluation of cortical malformations and associated brain abnormalities 7. (Evidence: Moderate)

Genetic Testing for Etiology: Conduct genetic testing to identify specific mutations (e.g., COQ2, ARX, LIS1) guiding prognosis and family planning 1 2 3 10. (Evidence: Moderate)

Multidisciplinary Support: Implement a multidisciplinary approach including neurology, genetics, developmental pediatrics, and physical therapy for comprehensive care 7. (Evidence: Expert opinion)

References

1 Rosado Santos R, Rodrigues M, Loureiro T. Prenatal Diagnosis of Lissencephaly Associated with Biallelic Pathologic Variants in the COQ2 Gene. Acta medica portuguesa 2023. link 2 Jagła M, Kruczek P, Kwinta P. Association between X-linked lissencephaly with ambiguous genitalia syndrome and lenticulostriate vasculopathy in neonate. Journal of clinical ultrasound : JCU 2008. link 3 Thomas MA, Duncan AM, Bardin C, Kaloustian VM. Lissencephaly with der(17)t(17;20)(p13.3;p12.2)mat. American journal of medical genetics. Part A 2004. link 4 Grishchuk AL, Kraehenbuehl R, Molnar M, Fleck O, Kohli J. Genetic and cytological characterization of the RecA-homologous proteins Rad51 and Dmc1 of Schizosaccharomyces pombe. Current genetics 2004. link 5 Plauchu H, Encha-Razavi F, Hermier M, Attia-Sobol J, Vitrey D, Verloes A. Lissencephaly type III, stippled epiphyses and loose, thick skin: a new recessively inherited syndrome. American journal of medical genetics 2001. link99:1<14::aid-ajmg1121>3.0.co;2-s) 6 Dobyns WB, Berry-Kravis E, Havernick NJ, Holden KR, Viskochil D. X-linked lissencephaly with absent corpus callosum and ambiguous genitalia. American journal of medical genetics 1999. link 7 Schuierer G, Kurlemann G, von Lengerke HJ. Neuroimaging in lissencephalies. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 1993. link 8 Lyon G, Raymond G, Mogami K, Gadisseux JF, Della Giustina E. Disorder of cerebellar foliation in Walker's lissencephaly and neu-laxova syndrome. Journal of neuropathology and experimental neurology 1993. link 9 Sarnat HB, Darwish HZ, Barth PG, Trevenen CL, Pinto A, Kotagal S et al.. Ependymal abnormalities in lissencephaly/pachygyria. Journal of neuropathology and experimental neurology 1993. link 10 Miny P, Holzgreve W, Horst J. Genetic factors in lissencephaly syndromes: a review. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 1993. link 11 Sharief N, Craze J, Summers D, Butler L, Wood CB. Miller-Dieker syndrome with ring chromosome 17. Archives of disease in childhood 1991. link 12 Simma B, Felber S, Maurer H, Gassner I, Krassnitzer S. MR and ultrasound findings in a case of cerebro-oculo-muscular-syndrome. Pediatric radiology 1990. link 13 Jellinger K, Rett A. Agyria-pachygyria (lissencephaly syndrome). Neuropadiatrie 1976. link

Lissencephaly